Cloning and characterization of a novel gene (C17orf25) from the deletion region on chromosome 17p13.3 in hepatocelular carcinoma

被引:20
作者
Qin, WX
Wan, DF
Sun, FY
Zhang, PP
Han, LW
Huang, Y
Jiang, HQ
Zhao, XT
He, M
Ye, Y
Cong, WM
Wu, MC
Zhang, LS
Yang, NW
Gu, JR
机构
[1] Shanghai Canc Inst, Natl Lab Oncogenes & Relates Genes, Shanghai 200032, Peoples R China
[2] Shanghai GeneCore Biotechnol, Shanghai 200233, Peoples R China
[3] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai 200433, Peoples R China
[4] Guangxi Med Univ, Canc Hosp, Nanning 500021, Peoples R China
关键词
chromosome; 17p13.3; loss of heterozygosity; hepatocellular carcinoma; transfection; novel human gene (C17orf25);
D O I
10.1038/sj.cr.7290088
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Using a combination of hybridization of PAC to a cDNA library and RACE technique, we isolated a novel cDNA, designated as C17orf25 (Chromosome 17 open reading frame 25, previously named it HC71A), from the deletion region on chromosome 17p13.3. The cDNA encodes a protein of 313 amino acids with a calculated molecular mass of 34.8 kDa. C17orf25 is divided into 10 exons and 9 introns, spanning 23 kb of genomic DNA. Northern blot analysis showed that the mRNA expression of C17orf25 was decreased in hepatocellular carcinoma samples as compared to adjacent noncancerous liver tissues from the same patients. The transfection of C17orf25 into the hepatocellular carcinoma cell SMMC7721 and overexpression could inhibit the cell growth. The above results indicate that C17orf25 is a novel human gene, and the cloning and preliminary characterization of C17orf25 is a prerequisite for further functional analysis of this novel gene in human hepatocellular carcinoma.
引用
收藏
页码:209 / 216
页数:8
相关论文
共 34 条
  • [1] INHIBITION OF PROLIFERATION OF HUMAN LEUKEMIA 60-CELLS BY METHYLGLYOXAL INVITRO
    AYOUB, FM
    ALLEN, RE
    THORNALLEY, PJ
    [J]. LEUKEMIA RESEARCH, 1993, 17 (05) : 397 - 401
  • [2] BIEGEL JA, 1992, CANCER RES, V52, P3391
  • [3] BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513
  • [4] COGEN PH, 1992, AM J HUM GENET, V50, P584
  • [5] Glyoxalase I activity in human prostate cancer: A potential marker and importance in chemotherapy
    Davidson, SD
    Cherry, JP
    Choudhury, MS
    Tazaki, H
    Mallouh, C
    Konno, S
    [J]. JOURNAL OF UROLOGY, 1999, 161 (02) : 690 - 691
  • [6] GLYOXALASE ACTIVITIES IN TUMOR AND NONTUMOR HUMAN UROGENITAL TISSUES
    DIILIO, C
    ANGELUCCI, S
    PENNELLI, A
    ZEZZA, A
    TENAGLIA, R
    SACCHETTA, P
    [J]. CANCER LETTERS, 1995, 96 (02) : 189 - 193
  • [7] IDENTIFICATION OF A CHROMOSOME-18Q GENE THAT IS ALTERED IN COLORECTAL CANCERS
    FEARON, ER
    CHO, KR
    NIGRO, JM
    KERN, SE
    SIMONS, JW
    RUPPERT, JM
    HAMILTON, SR
    PREISINGER, AC
    THOMAS, G
    KINZLER, KW
    VOGELSTEIN, B
    [J]. SCIENCE, 1990, 247 (4938) : 49 - 56
  • [8] A HUMAN DNA SEGMENT WITH PROPERTIES OF THE GENE THAT PREDISPOSES TO RETINOBLASTOMA AND OSTEOSARCOMA
    FRIEND, SH
    BERNARDS, R
    ROGELJ, S
    WEINBERG, RA
    RAPAPORT, JM
    ALBERT, DM
    DRYJA, TP
    [J]. NATURE, 1986, 323 (6089) : 643 - 646
  • [9] IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84
  • [10] Ittmann MM, 1996, PROSTATE, V28, P275